Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bardoxolone methyl in pulmonary hypertension (RANGER)
NCT03068130Phase 3Terminated
- Sponsor
- Biogen
- Start
- Apr 2017
- Primary completion
- Sep 2020
- Modality
- Classical Binding Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of bardoxolone methyl in pulmonary hypertension (PH), sponsored by Biogen. Started Apr 2017; status: terminated.
02
Drugs
bardoxolone methyl
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT03068130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068130.